drugset
drugset / Trial / NCT02077556

Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients

NCT02077556 ↗

Phase 4 Completed 14 enrolled National Taiwan University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to understand the effects of everolimus on tacrolimus pharmacokinetics (pk) in patients receiving de novo kidney transplants.

Timeline

Start
2014-04
Primary completion
2019-01-15
Completion
2019-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule 1 mg Oral
Comparator Mycophenolate Mofetil Small molecule 10 mg/kg Oral
Comparator Mycophenolate Mofetil Small molecule 15 mg/kg Oral
Subject Tacrolimus Small molecule 0.05 mg/kg Oral
Subject Tacrolimus Small molecule 0.075 mg/kg Oral
Background Methylprednisolone Other / unclassified 20 mg Intravenous
Background Prednisolone Other / unclassified 20 mg Oral

Indications

No indication recorded.